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 Abstract 
 Objectives: To explore the relationship between white matter hyperintensities (WMH) and the 
prevalence and course of depressive symptoms in mild Alzheimer’s disease (AD) and Lewy body 
dementia.  Design: This is a prospective cohort study conducted in secondary care outpatient 
clinics in western Norway.  Subjects: The study population consisted of 77 elderly people with 
mild dementia diagnosed according to standardised criteria.  Methods: Structured clinical inter-
views and physical, neurological, psychiatric, and neuropsychological examinations were per-
formed and routine blood tests were taken. Depression was assessed using the depression 
subitem of the Neuropsychiatric Inventory and the Montgomery-Åsberg Depression Rating 
Scale (MADRS). A standardised protocol for magnetic resonance imaging scan was used, and 
the volumes of WMH were quantified using an automated method, followed by manual editing. 
 Results: The volumes of total and frontal deep WMH were significantly and positively corre-
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lated with baseline severity of depressive symptoms, and depressed patients had significantly 
higher volumes of total and frontal deep WMH than non-depressed patients. Higher volumes 
of WMH were also associated with having a high MADRS score and incident and persistent de-
pression at follow-up. After adjustment for potential confounders, frontal deep WMH, in addi-
tion to prior depression and non-AD dementia, were still significantly associated with baseline 
depressive symptoms (p = 0.015, OR 3.703, 95% CI 1.294–10.593). Similar results emerged for to-
tal WMH.  Conclusion: In elderly people with mild dementia, volumes of WMH, in particular 
frontal deep WMH, were positively correlated with baseline severity of depressive symptoms, 
and seemed to be associated with persistent and incident depression at follow-up. Fur-
ther studies of the mechanisms that determine the course of depression in mild dementia are 
needed.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 White matter hyperintensities (WMH) are commonly found in cerebral T2-weighted 
magnetic resonance imaging (MRI) scans of elderly people. They seem to be particularly 
common in depression  [1] and dementia  [2, 3] . Etiologically, they have been associated with 
classic cardiovascular risk factors  [2] , including hypertension  [4] , and thus are considered to 
be a marker of cerebrovascular disease.
 In previous studies of elderly people, the severity of WMH has been found to predict 
worsening of voiding, mobility and cognition  [5] , as well as incident depression and depres-
sive symptoms  [6, 7] . The volume of WMH was associated with incident depression in a study 
of non-institutionalised elderly people  [7] , and severe deep white matter lesions predicted 
poor outcome in elderly patients with major depressive disorder  [8] .
 In subjects with dementia, frontal white matter lesions have been found to be associated 
with higher depression scores in cross-sectional studies  [3, 9] . However, a subsequent study 
failed to identify an association between WMH and psychiatric or other clinical variables in 
patients with Alzheimer’s disease (AD), using a visual scale  [10] . Thus, the implications of 
WMH with regard to incidence and prognosis of depression in subjects with mild dementia 
are still unclear. This is unfortunate, since depression is common in dementia  [11] , and is as-
sociated with poorer outcome in terms of cognitive ability  [12] , functioning  [13] , and quality 
of life  [14] .
 The aim of our study was to explore the relationship between WMH and the longitudi-
nal course of depressive symptoms in patients with mild dementia. We hypothesised that 
prevalence, incidence and prognosis of depressive symptoms are related to the volume of 
WMH and frontal deep WMH in particular. Such knowledge might enable a more accurate 
prognosis, but also increase our understanding of the underlying aetiologies of depression in 
dementia, and, most importantly, provide a strategy for potential prevention and treatment 
of depression in dementia.
 We have previously  [15] reported that depression is more common in dementia with 
Lewy bodies (DLB) compared to AD, and that WMH are more severe in mild AD and DLB 
patients than in non-demented elderly, using a novel semi-automatic volumetric analysis 
technique (Ketil Oppedal, Alzheimer’s Association International Conference 2011). A sec-
ondary aim was, therefore, to explore the association between volumetrically assessed WMH 
and depression in patients with Lewy body dementia (LBD) and AD separately. 
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 Methods 
 Subjects 
 We screened all referrals to the five outpatient clinics in geriatric medicine and old age 
psychiatry in the counties of Rogaland (Stavanger and Haugesund) and Hordaland (Bergen) 
in western Norway from March 2005 to March 2007 for patients with a first time diagnosis 
of mild dementia, i.e. a minimum Mini-Mental State Examination (MMSE) score of 20. 
From April 2007, we selectively recruited patients with DLB and Parkinson’s disease with 
dementia (PDD). Additionally, three neurology outpatient clinics in the same area were con-
tacted, and agreed to refer new dementia cases to one of the participating centres. The pa-
tients and caregivers were first seen by the study clinician, who performed a structured clin-
ical interview of demographic and clinical data. The comprehensive assessment procedure 
included a detailed history using a semi-structured interview, clinical examination, includ-
ing physical, neurological, psychiatric, and neuropsychological examinations, and routine 
blood tests. A total of 215 subjects fulfilled the inclusion criteria and constituted the baseline 
population. Patients were followed annually with the same assessment battery. 
 Ethical Issues 
 The study was approved by the regional Ethics Committee and the Norwegian authori-
ties for collection of medical data. The patients provided written consent to participate in the 
study after the study procedures had been explained in detail to the patient and a caregiver, 
usually the spouse or offspring.
 Dementia Diagnosis 
 Diagnoses were made after a detailed assessment as previously described  [16] , including 
the use of standardised clinical assessments of psychiatric symptoms, including hallucina-
tions and depression, parkinsonism and cognitive fluctuations, and MRI and blood tests. 
Cerebrospinal fluid was analysed in a subgroup of patients, and most patients with suspect-
ed DLB completed a dopamine transporter SPECT scan. Patients with acute delirium, ter-
minal illness, recently diagnosed with a major somatic illness, previous bipolar disorder or 
psychotic disorder were excluded.
 Two of the investigators independently applied the diagnostic criteria after baseline and 
2 years later. In cases of disagreement, and in patients fulfilling more than one set of opera-
tionalised diagnostic criteria, the final ascertainment was made based on consensus. In our 
present study, DLB and PDD were combined into one group (LBD), because these conditions 
have several clinical and biological similarities  [17, 18] .
 To determine apolipoprotein E (APOE) genotypes, genomic DNA was extracted from 
200   l EDTA blood using the QIAamp 96 DNA Blood Kit (Qiagen, Hilden, Germany). The 
APOE   2,   3 and   4 genotypes, which are determined by the combination of two SNPs 
(rs7412 and rs429358), were detected using the LightCycler  APOE Mutation Detection Kit 
(Roche Diagnostics, Mannheim, Germany). The assay was used according to the manufac-
turer’s instructions.
 Assessment of Depression 
 Depression was assessed using the depression subitem of the Neuropsychiatric Inven-
tory (NPId) and the Montgomery-Åsberg Depression Rating Scale (MADRS), and defined 
as previously described  [15] . The NPI was specifically designed to assess psychiatric symp-
toms in subjects with dementia, based on a structured interview of a caregiver  [19] , and the 
Norwegian version has been validated  [20] . It consists of 12 items, including a depression 
(dysphoria) item (NPId), with a maximum score of 12. A cutoff score of  6 1 was used 
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to detect any depression, and a cutoff score of  6 4 was used for clinically relevant depres-
sion  [21] .
 MADRS  [22] is a clinical interview with 10 items, each scored from 0 to 6, and was com-
pleted by an experienced licensed geriatrician or psychiatrist, after a training procedure. Rat-
ers met biannually to ensure similar administration of the instruments. A cutoff score of  6 7 
was used to detect at least mild depression  [23] , and a cutoff of  6 15 for clinically significant 
depression  [24] . MADRS has been found to provide a good measure of depression relatively 
independent from dementia severity  [25] . A history of clinically relevant (i.e. needing thera-
py) depression was asked for in the interview. Depression was assessed at baseline and at a 
follow-up evaluation 1 year later. Based on the MADRS cutoff scores, depression status was 
classified as never depressed, incident depression, persistent depression or recovered. The 
same procedure was performed based on the NPId cutoff scores.
 Assessment of Physical Comorbidity 
 For assessment of physical comorbidity, we employed the Cumulative Illness Rating 
Scale (CIRS), which measures the chronic medical illness burden, while taking into account 
the severity of chronic diseases. It was scored by a licensed and experienced geriatrician 
(S.P.N.) in accordance with the guidelines  [26] .
 MRI 
 The subjects were scanned at three different sites: the Stavanger University Hospital, the 
Haugesund Hospital, and the Haraldsplass Deaconess Hospital (Bergen). A 1.5-T scanner 
was used in all three centres (Philips Intera in Stavanger and Haugesund, and a 1.5T GE 
Signa Excite scanner in Bergen). MRI was done with the same scanner in each centre during 
the entire study period, and a common study imaging protocol was used. In some cases, 
scans were excluded due to insufficient image quality, not having both FLAIR and T1 im-
ages for the patient, or movement artefacts or other artefacts. 
 Volumetric Assessment of WMH 
 3D T1-Weighted Sequence 
 Stavanger. Repetition time (TR)/echo time (TE) 10.0/4.6 ms, flip angle 30.0°, 2-mm slice 
thickness with 1 mm spacing between the slices (1-mm slices with no gap), number of exci-
tations (NEX) 2, Matrix 256  ! 256, field of view (FOV) 26 cm. 
 Haugesund. TR/TE 20.0/4.6 ms, flip angle 30.0°, 1-mm slice thickness with 1 mm spac-
ing between the slices, NEX 1, Matrix 512  ! 512, FOV 26 cm.
 Bergen. TR/TE 8.2/3.1 ms, flip angle 7°, 1-mm slice thickness with 1 mm spacing be-
tween the slices, inversion time (TI) 500 ms, NEX 1, Matrix 256  ! 256, FOV 25.6 cm.
 FLAIR Sequence 
 Stavanger. TR/TE 6,000/100 ms, TI 2,000 ms, 4-mm slice thickness/1-mm gap, NEX 2, 
Matrix 256  ! 256.
 Haugesund. TR/TE/TI 6,000/110/2,000 ms, 4-mm slice thickness/1-mm gap, NEX 2, 
Matrix 512  ! 512.
 Bergen. TR/TE 7,927/105.4 ms, flip angle 90°, 4-mm slice thickness/1-mm gap, TI 1,981 
ms, NEX 1, Matrix 256  ! 256.
 Processing and Analysis of 3D T1-Weighted Scans and Axial FLAIR Images 
 Image analysis was performed according to a method developed and previously pub-
lished by Firbank et al.  [27] . This method requires sets of 3D T1-weighted scans and axial 
FLAIR images.
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 The non-brain regions were removed from the T1 image, using the segmentation rou-
tines in SPM5 (http://www.fil.ion.ucl.ac.uk/spm), and the WMH were segmented on a slice-
by-slice basis from the FLAIR image, with the images in native space, using a threshold de-
termined from the histogram of pixel intensities for each image slice.
 To explore the regional distribution of WMH throughout the brain, a region of interest 
(ROI) template in standard MNI space was used (Montreal Neurological Institute, http://
www.bic.mni.mcgill.ca). This ROI template was transformed from MNI space to the image 
space (FLAIR) of each subject by use of the normalization routines in SPM5, and the volumes 
of WMH in each ROI were calculated. The ROI map was based on the Brodmann template, 
which is provided as part of MRICro (http://www.psychology.nottingham.ac.uk/staff/crl/
lesion.html#brod). Further details can be found in the study by Firbank et al.  [28] .
 Because of the variability in image quality from the different centres participating in this 
study, we found it difficult to empirically choose a single threshold level that gave us good 
enough segmentation results in each subject, as deemed by a qualified radiologist (M.K.B.). 
A threshold level of 1.2 was chosen, since it gave an overestimation of the lesion load in every 
subject. Manual editing was then done to correct for this, by removing excess pixels using 
FSLView (http://www.fmrib.ox.ac.uk/fsl/index.html). 
 A specialist in internal medicine and geriatrics (H.S.) did the manual editing, blind to 
clinical data, after training by a consultant neuroradiologist (M.K.B.). They both edited the 
same 10 datasets twice; once at the beginning, to ensure good interrater reliability, and a sec-
ond time at the end to ensure that similar reliability still persisted and to evaluate intrarater 
reliability. The intraclass correlation coefficient was calculated to be 0.998 for interrater reli-
ability and 0.964 for intrarater reliability. The manually edited scans were then used in the 
further analysis of volumes of total and regional WMH. In order to compensate for interin-
dividual differences in total brain volumes, so as to be able to make comparisons between 
individual patients, we calculated the ratios of volumes of WMH to total brain volumes, 
which were then used in the statistical analyses.
 Visual Assessment of WMH 
 MRIs were also rated visually, using the Scheltens scale  [29] , by an experienced radiolo-
gist (O.J.G.) blind to clinical data. Interrater reliability with another neuroradiologist (M.K.B.) 
was analysed, based on 12 scans, finding an intraclass correlation coefficient of 0.923.
 Statistics 
 Baseline comparisons were made using the independent-samples t test, the   2 test or 
Fisher’s exact test, as appropriate. Depression scores for subjects with and without volumet-
ric MRI were compared using the independent-samples t test or the Mann-Whitney U test, 
as appropriate. Patients with and without depression were compared using the   2 test, the 
independent-samples t test or the Mann-Whitney U test, as appropriate. Spearman’s rank 
order correlations between WMH ratios, Scheltens scores and depression measures, includ-
ing change between baseline and follow-up, were performed. WMH ratios and Scheltens 
scores in the various depression status groups at baseline and follow-up were compared us-
ing the Mann-Whitney U test. Analysis of covariance (ANCOVA) was performed to control 
for effects of centre affiliation and other potential confounders. p values  ! 0.05 (two-tailed) 
were considered statistically significant. Potential predictor variables were included in step-
wise multiple logistic regression analyses together with frontal deep WMH ratios or total 
WMH ratios, using the various definitions of depression as response variable. For these 
analyses, the frontal deep and total WMH ratios were multiplied by 100 due to very small 
absolute values. 
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 Subjects with missing data for a given analysis were excluded from that specific analysis. 
For determination of the normality status of continuous variables, we used the Kolmogo-
rov-Smirnov test. All statistical tests were performed using PASW Statistics 18, release 
18.0.1.
 Results 
 Of the 215 participants included at baseline, 9 were excluded later. Of these, 5 were redi-
agnosed as having mild cognitive impairment, 2 withdrew from the study and 2 were ex-
cluded due to lack of complete data. A total of 190 of the 206 (92%) remaining participants 
completed the 1-year follow-up examination. Death was the major reason for dropout, as 10 
died during the first year follow-up period. The other reasons for not being seen at the 1-year 
follow-up were patient refusal (n = 5) or caregiver refusal (n = 1).
 MRI scans of 77 participants were of sufficient quality for volumetric WMH analysis, 
and 137 scans could be rated semiquantitatively according to the Scheltens scale. The cor-
relations between the WMH (total and deep frontal) ratios and the Scheltens (total and fron-
tal) scores were highly significant (Spearman’s rho 0.838 and 0.839, respectively, p  ! 0.001). 
 Among the patients with scans included in the volumetric analyses (‘completers’), there 
was a significantly higher proportion of subjects with AD and a lower proportion with DLB/
PDD, and they had a somewhat shorter mean disease duration than patients who were not 
included in the volumetric analyses (‘non-completers’). Otherwise, there were no significant 
differences between the 77 completers and the 129 non-completers in demographic and clin-
ical variables at baseline ( table 1 ).
 There were no significant differences between the 137 subjects with scans rated with the 
Scheltens scale and the rest of the subjects (n = 69) with regard to baseline clinical character-
istics (data not shown). 
 At baseline, 33 of the 77 patients included in the volumetric analyses were depressed and 
44 were not depressed, using a MADRS cutoff score of  6 7. There were no significant differ-
ences between depressed and non-depressed patients with regard to sex, use of psychoactive 
medications, MMSE scores, CIRS total scores, and APOE   4 at baseline, but the depressed 
were significantly younger and included significantly more patients with prior depression 
and patients with non-AD dementia ( table 2 ). However, the significance of the age difference 
disappeared after controlling for centre affiliation (data not shown). 
 Using a MADRS cutoff score of  6 15, 14 were depressed and 63 not depressed. The only 
significant differences regarding the above-mentioned variables were that the depressed sig-
nificantly more often had also prior depression (9/14 vs. 13/63, p = 0.003), and significantly 
more often were using antidepressants (8/14 vs. 15/63, p = 0.024). 
 At the 1-year follow-up, there were no significant differences in the proportions of the 
depressed and non-depressed receiving antidepressants (MADRS cutoff  6 7; 13/24 vs. 13/33, 
p = 0.403, MADRS cutoff  6 15; 3/5 vs. 23/52, p = 0.651).
 Baseline Analyses 
 At baseline, significant positive correlations with MADRS scores were found for both 
total (Spearman’s correlation coefficient 0.274, p = 0.016) and frontal deep WMH ratios 
(Spearman’s correlation coefficient 0.238, p = 0.037), and patients with MADRS scores of  6 7 
had significantly higher total and frontal deep WMH ratios than patients with MADRS 
scores of  ! 7 (p = 0.011 and p = 0.023, respectively). Similarly, patients with MADRS scores 
of  6 15 had higher total and frontal deep WMH ratios (p = 0.018 and p = 0.015, respectively) 
than those with MADRS scores of 14 or lower.
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Table 1.  Baseline clinical characteristics of subjects who participated in the volumetric MRI study (com-
pleters) and those who did not participate (non-completers)
Non-completers 
(n = 129)
Completers 
(n = 77)
p value Participants 
missing data 
(n = 206)
Age 77.0 (71–82) 76.9 (70–81) 0.613 0
Women 72 (55.8) 50 (64.9) 0.195 0
Years of education 8.5 (7–11) 8.5 (7–11) 0.613 27
MMSE 23 (22–26) 24 (23–26) 0.230 4
AD 74 (57.4) 59 (76.6) 0.005 0
DLB/PDD 42 (32.6) 12 (15.6) 0.007 0
VaD 9 (7) 2 (2.6) 0.216 0
FTD/alcoholic dementia 4 (3.1) 4 (5.2) 0.475 0
Mean disease duration (min–max), years 2.9 (0.5–15) 2.3 (0.5–12) 0.045 13
Prior depression 49 (40) 22 (29) 0.160 7
CIRS total 6 (4–8) 6 (4–7) 0.311 2
Use of antipsychotics 5 (3.9) 3 (3.9) 1.000 3
Use of anxiolytics/hypnotics 20 (15.6) 8 (10.5) 0.289 2
Use of antidepressants 43 (33.6) 23 (30.3) 0.625 2
MADRS 8 (3.3–12.8) 5 (3–12.5) 0.446 1
MADRS ≥7 70 (55) 33 (43) 0.135 1
MADRS ≥15 21 (16) 14 (18) 0.892 1
APOE4 ≥1 allele, fraction (%) 58/95 (61) 32/51 (63) 0.842 111
V alues are median (IQR) or n (%), unless otherwise indicated. 
VaD = Vascular dementia; FTD = frontotemporal dementia; MMSE: normal range 24–30; CIRS: range 
0 (no impairment)–52 (extremely severe impairment); MADRS: normal range 0–6. 
Significant results are shown in bold.
Table 2.  Baseline clinical characteristics of non-depressed versus depressed patients (according to the 
MADRS score)
MADRS baseline <7 
(n = 44)
MADRS baseline ≥7 
(n = 33)
p value
Age 78 (71–81) 73 (68–80) 0.049*
Women 29 (66) 21 (64) 0.839
Prior depression 8 (18) 14 (44) 0.030
Use of antidepressant 11 (25) 12 (36) 0.358
Use of anxiolytic/hypnotic 2 (5) 6 (19) 0.063
Use of antipsychotic 2 (5) 1 (3) 1.000
CIRS total 6 (4–7) 6 (3.5–7.5) 0.769
MMSE 24 (22–25) 24 (23–26) 0.268
Dementia diagnosis (non-AD) 5 (11) 13 (39) 0.007
APOE4 ≥1 allele, fraction (%) 17/28 (61) 15/23 (65) 0.968
Values are median (IQR) or n (%), unless otherwise indicated. 
MADRS: normal range 0–6; CIRS: range 0 (no impairment)–52 (extremely severe impairment); 
MMSE: normal range 24–30. 
* Not significant after controlling for centre affiliation. Significant results are shown in bold.
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 In contrast, there were no significant correlations between baseline NPId and total and 
frontal WMH ratios (p = 0.163 and 0.149, respectively). However, when using a NPId depres-
sion cutoff score of  6 4, the depressed (n = 16/75) had significantly higher total and frontal 
deep WMH ratios (p = 0.010 and p = 0.019, respectively). No significant differences were 
found using a NPId depression cutoff score of  6 1.
 When analysing AD and LBD patients separately, a trend towards a significant positive 
correlation was found between frontal deep WMH ratios and baseline MADRS scores in AD 
patients (Spearman’s correlation coefficient 0.254, p = 0.052), but not in LBD patients (Spear-
man’s correlation coefficient 0.467, p = 0.126). Total WMH ratios did not differ between AD 
or LBD patients according to depression (data not shown).
 No significant associations were found between Scheltens total and frontal scores and the 
depression measures at baseline, except that patients with a NPId score of  6 4 had signifi-
cantly higher Scheltens deep frontal scores (p = 0.034) than those with a NPId score of  ! 4.
 We performed stepwise multiple logistic regression in order to assess the potential con-
founding effects and relative contributions of variables other than total and frontal deep 
WMH on the odds of having a MADRS score of  6 7 at baseline. 
 Due to high correlation between total and frontal deep WMH (correlation coefficient 
0.797, p  ! 0.001), we performed separate analyses for these variables. The initial models con-
tained, in addition to the WMH variable, five other independent variables (non-AD vs. AD, 
age at baseline, sex, CIRS total score and prior depression), all of which have been associated 
with depression in previous studies  [15, 30–33] .
 The final model concerning frontal deep WMH was statistically significant (Omnibus test 
of model coefficients p  ! 0.0005). Frontal deep WMH, in addition to prior depression and type 
of dementia, were still significantly associated with a baseline MADRS score of  6 7 ( table 3 a).
 Similar results emerged for total WMH. The final model was statistically significant 
(Omnibus test of model coefficients p  ! 0.0005), and total WMH were significantly associ-
ated with a baseline MADRS score of  6 7 ( table 3 b). 
 Due to the low numbers of patients having clinically significant depression (i.e. MADRS 
 6 15 or NPId  6 4) at baseline and at follow-up (MADRS n = 5/65 and NPId n = 16/67), only 
Table 3a. Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood 
of a MADRS score of ≥7 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Frontal deep WMH ratio 1.309 0.536 0.015 3.703 (1.294–10.593)
Non-AD versus AD* –2.055 0.666 0.002 0.128 (0.035–0.472)
Prior depression 1.321 0.611 0.031 3.746 (1.130–12.414)
Table 3b. Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a 
MADRS score of ≥7 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Total WMH ratio 0.328 0.124 0.008 1.388 (1.088–1.771)
Non-AD versus AD* –1.841 0.656 0.005 0.159 (0.044–0.574)
Prior depression 1.300 0.605 0.031 3.671 (1.122–12.006)
* Non-AD = 0, AD = 1. MADRS: normal range 0–6.
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two independent variables could be used in the multiple logistic regression analyses using 
these cutoffs. For the same reason, these analyses could be performed only regarding the ef-
fect of the independent variables on the risk of being clinically depressed at baseline, but not 
at follow-up. Based on the results of previous analyses, as well as bivariate logistic regression 
analyses (data not shown), prior depression yes/no or AD/non-AD were entered as indepen-
dent variables in stepwise multiple logistic regression analyses, together with either frontal 
deep WMH ratios or total WMH ratios. 
 Using MADRS scores of  ! 15 versus  6 15 as the response variable, both a higher frontal 
deep WMH ratio and prior depression were significant predictors of having a MADRS score of 
 6 15. Replacing prior depression with AD/non-AD in the analysis, only the frontal deep WMH 
ratio remained significant. Similar findings emerged for the total WMH ratio ( table 4 a–d).
 Using NPId scores of  ! 4 versus  6 4 as the response variable, only prior depression was 
significant when entered with frontal deep WMH ratios into the analysis (the validity of the 
model fit was uncertain, Pearson   2 goodness-of-fit value = 0.000). However, only higher 
Table 4a. Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood 
of a MADRS score of ≥15 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Frontal deep WMH ratio 0.855 0.379 0.024 2.350 (1.117–4.943)
Prior depression 1.824 0.672 0.007 6.199 (1.662–23.120)
Table 4b. Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood 
of a MADRS score of ≥15 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Frontal deep WMH ratio 0.985 0.388 0.011 2.678 (1.251–5.733)
Non-AD versus AD* –1.255 0.682 0.066 0.285 (0.075–1.085)
Table 4c. Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a 
MADRS score of ≥15 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Total WMH ratio 0.225 0.113 0.046 1.252 (1.004–1.562)
Prior depression 1.781 0.663 0.007 5.939 (1.620–21.769)
Table 4d. Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a 
MADRS score of ≥15 at baseline
B SE p Odds ratio exp.(B) 
(95% CI)
Total WMH ratio (final step) 0.265 0.108 0.014 1.304 (1.055–1.611)
Non-AD versus AD* (step 1) –1.040 0.663 0.116 0.353 (0.096–1.295)
* Non-AD = 0, AD = 1. MADRS: normal range 0–6.
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frontal deep WMH ratios were significantly associated with NPId scores of  6 4 when entered 
into the analysis with AD/non-AD. Replacing frontal deep WMH ratios with total WMH 
ratios, higher total WMH ratios, but not prior depression or AD/non-AD were significantly 
associated with a NPId score of  6 4 ( table 5 a–d).
 All the models having clinically significant depression as response variable were statisti-
cally significant, i.e. Omnibus test of model coefficients p  ! 0.05.
 Course of Depression 
 The median change in MADRS scores was +1.0. Of the 206 subjects, 47% had a MADRS 
score of  6 7 at the 1-year follow-up, and 12% had a MADRS score of  6 15. Using a MADRS 
cutoff score for depression of  6 15, 20 out of 35 (57%) recovered and 5% had incident depres-
sion. Baseline total and frontal deep WMH were not correlated with MADRS (p = 0.459 and 
p = 0.537, respectively) or NPId (p = 0.697 and p = 0.329, respectively) scores at the 1-year 
follow-up. 
Table 5a. Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood 
of a NPId score of ≥4 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Frontal deep WMH ratio – – – –
Prior depression 1.242 0.591 0.036 3.462 (1.087–11.021)
Table 5b. Multiple logistic regression analysis of the effect of frontal deep WMH volume on the likelihood 
of a NPId score of ≥4 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Frontal deep WMH ratio (final step) 0.703 0.348 0.044 2.019 (1.021–3.993)
Non-AD versus AD* (step 1) –0.542 0.655 0.408 0.581 (0.161–2.098)
Table 5c. Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a 
NPId score of ≥4 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Total WMH ratio 0.275 0.108 0.011 1.317 (1.066–1.628)
Prior depression 1.067 0.632 0.091 2.908 (0.842–10.038)
Table 5d. Multiple logistic regression analysis of the effect of total WMH volume on the likelihood of a 
NPId score of ≥4 at baseline
B SE p Odds ratio exp. (B) 
(95% CI)
Total WMH ratio (final step) 0.304 0.107 0.005 1.356 (1.099–1.673)
Non-AD versus AD* (step 1) –0.348 0.686 0.612 0.706 (0.184–2.709)
* Non-AD = 0, AD = 1. MADRS: normal range 0–6.
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 Using cutoff scores for depression of  6 7 and  6 1, respectively, for MADRS and NPId, 
there were no significant differences in WMH ratios when comparing patients with favour-
able (i.e. never depressed or remission) and unfavourable (i.e. new depression or persistence) 
courses of depression, in remission versus persistent depression, or between patients who had 
never had depression versus those with persistent depression. Finally, changes between base-
line and follow-up MADRS and NPId scores were not significantly correlated with WMH 
ratios at baseline.
 However, patients with MADRS scores of  6 15 at follow-up had significantly higher 
baseline volumes of both total and frontal deep WMH (p = 0.012 and p =0.006, respectively) 
than those with a MADRS score of  ^  14. Furthermore, patients with an unfavourable course 
according to MADRS scores had significantly higher volumes of both total and frontal deep 
WMH (p = 0.012 and p = 0.006, respectively). In the NPId, this was the case only for frontal 
deep WMH (p = 0.047). There were no significant differences between patients with remis-
sion compared to those with persistent depression with respect to WMH volumes. When 
comparing patients with no depression and patients with persistent depression, the only sig-
nificant difference was that patients with persistent depression based on the NPId had sig-
nificantly higher volumes of frontal deep WMH (p = 0.031). There were no other associations 
using the NPId  6 4 cutoff score.
 No significant associations were found between Scheltens total and frontal scores and 
the course of depression variables.
 Discussion 
 Main Findings 
 The main finding of this study was that the volume ratios of WMH were positively and 
independently correlated with depression at baseline. Furthermore, the results suggest that 
having higher WMH volume ratios at baseline may be associated with a higher risk of hav-
ing depression or an unfavourable course of depression at the 1-year follow-up.
 Interpretation 
 The results of our study are consistent with some previous studies  [3, 9] , and similar 
findings have been reported also in non-demented elderly  [7, 34] . However, other studies did 
not find such a relationship, although this was based on a combination of psychiatric symp-
toms rather than a specific measure of depression  [10] . Thus, our findings support the hy-
pothesis that WMH predispose elderly individuals, with or without dementia, to developing 
depression. One possible mechanism is disruption of fibre tracts connecting cortical and 
subcortical structures involved in the regulation of mood  [1] .
 However, our hypothesis that the prognosis of depressive symptoms in persons with 
mild dementia is related to the volume of WMH, and frontal deep WMH in particular, was 
less robustly supported. One partial explanation could be the rather low total number of 
patients, and consequently a low number of patients having clinically significant depres-
sion in our study, resulting in limited possibilities for multivariable statistical analysis. 
Moreover, cerebrovascular disease is a chronic condition that may exert its major influence 
early in the course of dementia, and other factors, intrinsic and extrinsic, could be more 
important determinants of the course of depression at later stages. These factors may in-
clude neurotransmitter changes  [35] , inflammation  [36] , physical comorbidity  [37] , envi-
ronmental factors  [38] , treatment  [39] , and disability  [6] . Of note, we recently found that 
worsening of depressive symptoms was associated with a more rapid cognitive decline, sug-
gesting that the degenerative changes at this stage of the disease are the key determinants 
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of depression in people with early AD and LBD  [11] . Finally, the less-than-robust support 
for our hypothesis might be related to longitudinal changes in depression in elderly patients 
with dementia  [40] .
 The observed trend towards a differential relationship between WMH and depression 
in AD versus LBD is most likely due to differences in statistical power, due to the small num-
ber of LBD patients.
 We did, somewhat surprisingly, find almost no correlations or associations between 
Scheltens scores and depression variables. This is in contrast to findings in a previous study 
 [3] . Notably, this previous study included persons with more advanced dementia (mean 
MMSE scores of 13.6–18.2) than our study. This discrepancy could also be due to visual scor-
ing methods, e.g. the Scheltens scale, being less sensitive than volumetric methods  [41] , de-
spite the high correlations between the results of these methods. Unlike volumetric methods, 
visual rating scales, such as the Scheltens scale, display ceiling effects and poor discrimina-
tion of absolute lesion volumes  [41] . 
 Strengths and Limitations 
 Strengths of this study include the longitudinal design and the quantitative method for 
measuring WMH. Limitations include the relatively low number of cases, which limits the 
statistical power of the study, particularly for the LBD group. Moreover, our sample was re-
cruited from secondary care outpatient clinics, and may therefore not be representative of 
the general population with mild dementia. Thus, the generalisability of our findings may 
be limited. The change in depression was relatively small, probably due to the relatively short 
study period, which also limits the statistical power to detect associations with the longitu-
dinal course of depression. A longer observation period might have increased the likelihood 
of finding an association between WMH and the course of depression. Another possible 
limitation is that depression was assessed using scale scores rather than using a structured 
psychiatric interview and diagnoses based on standardised criteria. The diagnosis in the ma-
jority of cases was clinical, and thus misdiagnosis cannot be excluded. However, standardised 
and validated scales were used, also to support the diagnosis of DLB, where the clinical di-
agnosis was confirmed in all 7 patients who came to autopsy [Dag Aarsland, pers. commun., 
2011]. We combined patients with DLB and PDD into one LBD group. Although the two syn-
dromes differ in the temporal sequence of symptoms and in the relative severity of cortical 
amyloid pathology, we consider them sufficiently similar to be combined in a study of WMH. 
Furthermore, patients were followed longitudinally, which also is likely to increase diagnos-
tic accuracy. We used two different measures of depression, one observer-based (MADRS) 
and one carer-based (NPId). Stronger associations with WMH were found for MADRS, sug-
gesting that this is a more sensitive measure of depression in mild dementia. Finally, since 
this was a naturalistic study, we could not control for possible treatment changes during the 
study period, which might influence the course of depression and thus mask a possible rela-
tionship between WMH and the course of depression. 
 Clinical Implications and Future Research 
 One implication of our findings is that prevention or reduction of WMH, if possible, 
could lessen the burden of depression and depressive symptoms in persons with mild demen-
tia. This might be accomplished by means of therapies directed against established risk fac-
tors for stroke and WMH, such as hypertension and diabetes  [42] . Such preventive measures, 
which would at least have several other positive health effects, should probably be initiated 
in midlife  [43] . The importance of such potentially preventive strategies is increased in light 
of recent studies suggesting that antidepressants may not be effective for depressed patients 
with dementia  [44] . 
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 Further studies of the mechanisms that determine the course of depression in people 
with mild dementia are clearly called for. These studies should be sufficiently powered and 
of longer duration, as well as including patients with non-AD dementias such as LBD and 
vascular dementia.
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